Albert Font

A Novel Anti-Apoptosis Gene: Re-expression of Survivin Messenger RNA as a Prognosis Marker in Non–Small-Cell Lung Cancers

Mariano Monzó, Rafael Rosell, Enriqueta Felip et al. · Journal of Clinical Oncology · 1999 · 496 citations

Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective study

Jesús García-Donás, Emilio Esteban, Luis J. Leandro‐García et al. · The Lancet Oncology · 2011 · 220 citations

Urology, Genitourinary Cancer, Medicine +7

Phase I-II Study of Paclitaxel, Cisplatin, and Gemcitabine in Advanced Transitional-Cell Carcinoma of the Urothelium

Joaquim Bellmunt, Vicente Guillém, Luis Paz‐Ares et al. · Journal of Clinical Oncology · 2000 · 191 citations

Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study

Arlene O. Siefker‐Radtke, Andrea Necchi, Se Hoon Park et al. · The Lancet Oncology · 2022 · 162 citations · Full text

Urology, Oncology, Metastatic Urothelial Carcinoma +7

Gemcitabine and carboplatin in advanced transitional cell carcinoma of the urinary tract

Miquel Nogué‐Aliguer, Joan Carles, A. Arriví et al. · Cancer · 2003 · 98 citations · Full text